Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.625    -0.025 (-3.85%)
Bid:
0.60
Ask:
0.65
Spread: 0.05 (8.333%)
Market Cap: £2.83m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Director Declaration

11 Feb 2013 15:23

RNS Number : 6239X
Physiomics PLC
11 February 2013
Ā 



Physiomics plc

Ā 

(the "Company")

Ā 

Directors Details

Ā 

The Company notes the announcement of Angel Biotechnology plc ("Angel") made earlier today confirming that administrators have been appointed with immediate effect.

Ā 

Paul Harper, a director of Physiomics, was a director of Angel until December 2012, and accordingly is required to make this notification pursuant to Rule 17 of the AIM Rules for Companies.

Ā 

Enquiries:

Ā 

Physiomics plc

Dr Mark Chadwick, CEOĀ 

+44 (0)1865 784980

Ā 

WH Ireland Limited

Katy Mitchell

+44 (0) 161 832 2174

Ā 

Ā 

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
RDNLLFFEFFILLIV
Date   Source Headline
28th Apr 20202:50 pmRNSConference attendance and presentation
16th Apr 20207:00 amRNSConfirmation of Twitter account
9th Apr 202012:28 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSAwarded further Bicycle Therapeutics contract
19th Mar 20207:00 amRNSCOVID-19 update
10th Mar 20207:00 amRNSNIHR i4i award
5th Mar 20207:00 amRNSPhysiomics awarded further contract by Merck
3rd Mar 20207:00 amRNSAwarded two further contracts by Bicycle
27th Dec 20193:45 pmRNSHolding(s) in Company
23rd Dec 20197:00 amRNSContract award
20th Dec 201910:30 amRNSMerck Contracts
19th Nov 201912:52 pmRNSResult of AGM
21st Oct 20197:00 amRNSDispatch of Annual Report and Notice of AGM
30th Sep 20197:00 amRNSFinal Results for the Year Ended 30 June 2019
5th Aug 20197:00 amRNSDirector Dealing
30th Jul 20197:00 amRNSTrading Update
22nd Jul 20199:03 amRNSHolding(s) in Company
8th Jul 20197:00 amRNSAgreement with Bicycle and Cancer Research UK
2nd Jul 20191:30 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSContract Award
31st May 20197:00 amRNSChange of Adviser
14th May 20197:00 amRNSInnovate UK Award Project
3rd May 201912:00 pmRNSPhysiomics participates at NIHR event
30th Apr 20192:00 pmRNSConference attendance and presentation
27th Mar 20191:00 pmRNSIssue of Options
26th Mar 20191:00 pmRNSAIM Rule 26 Website Change
20th Mar 20197:00 amRNSConference Attendance and Presentation
21st Feb 20197:00 amRNSInterim Results
7th Jan 20197:00 amRNSConference Attendance
3rd Jan 20197:00 amRNSStrategic Collaboration
17th Dec 20187:00 amRNSRenewal of Agreement with Merck
20th Nov 201812:56 pmRNSResult of AGM
15th Oct 20181:00 pmRNSDispatch of Annual Report and Shareholder Circular
8th Oct 20187:00 amRNSFinal Results for the Year Ended 30 June 2018
9th Aug 20187:00 amRNSContract award
2nd Jul 20181:57 pmRNSPhysiomics Expands Technical Team
21st Jun 20187:00 amRNSTrading Update
11th Jun 20184:05 pmRNSUpdated Website
23rd May 20187:00 amRNSPlacing
26th Apr 201811:06 amRNSContract Award
6th Apr 20182:40 pmRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSPhysiomics to Present at AACR Annual Meeting
27th Mar 20185:23 pmRNSIssue of Options
14th Mar 20187:00 amRNSAward of New Innovate UK Grant
12th Mar 20187:00 amRNSCompletion of Innovate UK Grant Project
19th Feb 20187:00 amRNSInterim Results Statement
9th Feb 20187:00 amRNSContract Award
26th Jan 20187:00 amRNSNew Major Pharmaceutical Client
25th Jan 20181:34 pmRNSHolding(s) in Company
24th Jan 20188:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.